Chennai Meenakshi Hospital's Q3 Results Show Mixed Performance

Chennai Meenakshi Multispeciality Hospital, a microcap healthcare services company, has recently declared its financial results for the quarter ended September 2023. The company's net sales for the quarter showed a growth of 8.45% compared to the previous quarter, which had a decline of 12.38%. The standalone net profit also saw a significant improvement, with a growth of 100% compared to a decline of 92% in the previous quarter.

The operating profit (PBDIT) excluding other income also showed a positive growth of 30.95% compared to a decline of 60% in the previous quarter. However, the interest expenses remained flat compared to a slight increase of 4.55% in the previous quarter. The operating profit margin (excluding other income) also showed improvement from the previous quarter.

According to MarketsMOJO, a leading stock analysis platform, the stock call for Chennai Meena is 'Hold'. The company's financial performance for the quarter has been flat, with a score of -1 compared to -2 in the last 3 months. However, there are some positive aspects to the financial results.

The company's profit after tax (PAT) for the nine-month period is higher at Rs 0.31 crore compared to the preceding 12-month period ended September 2023, which was Rs 0.22 crore. This shows a growth in profits and the company has already surpassed its sales from the previous 12 months in just 9 months.

On the other hand, the company's operating cash flow for the year is at its lowest in the last three years, at Rs 2.95 crore. This indicates a decline in cash revenues from business operations.

Overall, Chennai Meenakshi Multispeciality Hospital has shown a mixed financial performance for the quarter ended September 2023. While there are some positive aspects, there are also areas that need improvement. Investors are advised to hold their position and keep a close eye on the company's future financial results.